세계의 파클리탁셀(Paclitaxel) 주사제 시장 보고서(2025년)

Paclitaxel Injection Global Market Report 2025

US $ 4,490 ￦ 6,231,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 9,006,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 11,782,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

파클리탁셀 주사제 시장 규모는 향후 몇 년 동안 빠르게 성장할 것으로 예상되며, 2029년까지 CAGR 12.9%로 111억 7,000만 달러에 달할 것으로 예상됩니다. 예측 기간 동안의 성장은 개인 맞춤형 의료 접근법, 바이오시밀러 개발, 고령화에 따른 암 부담 증가, 약물 전달 시스템의 발전, 헬스케어 정책의 변화 등에 기인하는 것으로 보입니다. 예측 기간 동안 주요 동향으로는 종양학에서의 AI 통합, 원격의료 및 원격 헬스케어 서비스, 약물 전달 기술 혁신, 약물 전달 기술의 통합, 바이오시밀러의 부상 등을 꼽을 수 있습니다.

예상되는 유방암 사례 증가는 향후 파클리탁셀 주사제 시장의 성장을 견인할 것으로 예상됩니다. 유방암은 유방의 비정상적인 세포 증식을 특징으로 하며, 종종 종양을 형성하고 유행하는 질환입니다. 화학요법인 파클리탁셀 주사제는 미세혈관에 결합하여 암세포의 증식을 억제함으로써 유방암 치료에 도움을 주고 있습니다. 미국암협회의 2023년 1월 추정에 따르면, 미국에서는 2023년 침윤성 유방암 신규 환자가 약 297,790명, 2023년에는 약 43,700명이 사망할 것으로 예상됩니다. 따라서 유방암 발병률 증가는 파클리탁셀 주사제 시장의 성장을 가속하는 중요한 요인입니다.

암 발병률 증가는 향후 파클리탁셀 주사제 시장의 성장을 가속할 것으로 예상됩니다. 담배와 알코올 소비 증가, 흡연의 확산 등의 요인이 전 세계 암 환자 수 증가에 기여하고 있습니다. 파클리탁셀은 유방암, 폐암, 난소암 등 다양한 암 치료에 널리 사용되는 화학요법제입니다. 암 환자 수가 증가함에 따라 화학요법에 대한 수요도 증가하고 있으며, 파클리탁셀은 많은 치료 요법에 필수적인 요소로 자리 잡고 있습니다. 예를 들어, 2024년 5월, 암 연구 및 교육에 중점을 둔 정부 기관인 미국 국립암연구소는 2040년까지 전 세계 연간 신규 암 환자 수가 2,990만 명에 달하고 암 관련 사망자 수가 1,530만 명에 달할 것으로 예측했습니다. 따라서 암 발생률 증가는 파클리탁셀 주사제 시장의 성장을 가속하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 코로나, 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

• 세계 파클리탁셀 주사제 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 성장 촉진요인 및 억제요인)
• 최종 이용 산업 분석
• 세계의 파클리탁셀 주사제 시장 : 성장률 분석
• 세계의 파클리탁셀 주사제 시장 실적 : 규모와 성장, 2019-2024
• 세계의 파클리탁셀 주사제 시장 예측 : 규모와 성장, 2024-2029, 2034F
• 세계 파클리탁셀 주사제 전체 시장(TAM)

제6장 시장 세분화

• 세계의 파클리탁셀 주사제 시장 : 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 천연 파클리탁셀
• 반합성 파클리탁셀
• 세계의 파클리탁셀 주사제 시장 : 약물 강도별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 10 mg 또는 mL
• 20 mg 또는 mL
• 30 mg 또는 mL
• 세계의 파클리탁셀 주사제 시장 적응증별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 유방암
• 전립선암
• 고환암
• 비소세포 폐암
• 폐암
• 기타 적응증
• 세계의 파클리탁셀 주사제 시장 : 유통 채널별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 병원 약국
• 온라인 약국
• 소매 약국
• 세계의 파클리탁셀 주사제 시장 : 최종사용자별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 병원
• 클리닉
• 암 연구센터
• 세계의 파클리탁셀 주사제 시장 : 천연 파클리탁셀별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• Paclitaxel From Pacific Yew Tree
• Paclitaxel From Other Natural Sources
• 세계의 파클리탁셀 주사제 시장 : 반합성 파클리탁셀별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• Docetaxel (Taxotere)
• 기타 반합성 변종

제7장 지역별/국가별 분석

• 세계의 파클리탁셀 주사제 시장 : 지역별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 세계의 파클리탁셀 주사제 시장 : 국가별, 분석과 예측, 2019-2024, 2024-2029F, 2034F

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

• 파클리탁셀 주사제 시장 : 경쟁 구도
• 파클리탁셀 주사제 시장 : 기업 개요
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
  • Fresenius Kabi Oncology Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Viatris Inc. Overview, Products and Services, Strategy and Financial Analysis

제31장 기타 주요 기업 및 혁신 기업

• Teva Pharmaceutical Industries Limited
• Sandoz International GmbH
• Hospira Inc.
• Dr. Reddy's Laboratories Ltd.
• Apotex Inc.
• Intas Pharmaceuticals Ltd.
• Zydus Lifesciences Limited
• Torrent Pharmaceuticals Ltd.
• Luye Pharma Group
• Biological E Limited
• Alembic Pharmaceuticals Limited
• Khandelwal Laboratories Pvt. Ltd.
• Gland Pharma Limited
• Abraxis Bio Science Inc.
• Novasep Holding SAS

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

• 파클리탁셀 주사제 시장(2029년) : 새로운 기회를 제공하는 국가
• 파클리탁셀 주사제 시장(2029년) : 새로운 기회를 제공하는 부문
• 파클리탁셀 주사제 시장(2029년) : 성장 전략
  • 시장 동향에 근거한 전략
  • 경쟁 전략

제36장 부록

LSH

영문 목차

영문목차

Paclitaxel injection is a chemotherapy drug used in cancer treatment, typically administered through infusion into a vein in a hospital or clinic by a trained healthcare professional. Its mechanism of action involves disrupting the division and growth of cancer cells, ultimately leading to their destruction.

The primary types of paclitaxel injection are natural paclitaxel and semi-synthetic paclitaxel. Natural paclitaxel is a tetracyclic diterpenoid initially extracted from sources such as the bark of the Pacific yew tree, Taxus brevifolia. It is available in various drug strengths, including 10mg/ml, 20mg/ml, and 30mg/ml, and is utilized for the treatment of various cancers such as breast cancer, prostate cancer, testicular cancer, non-small cell lung cancer, lung cancer, among others. These injections are distributed through various channels, including hospital pharmacies, online pharmacies, and retail pharmacies, and are used by end-users such as hospitals, clinics, and cancer research institutes.

The paclitaxel injection market research report is one of a series of new reports from The Business Research Company that provides paclitaxel injection market statistics, including paclitaxel injection industry global market size, regional shares, competitors with a paclitaxel injection market share, detailed paclitaxel injection market segments, market trends and opportunities, and any further data you may need to thrive in the paclitaxel injection industry. This paclitaxel injection market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The paclitaxel injection market size has grown rapidly in recent years. It will grow from $6.02 billion in 2024 to $6.87 billion in 2025 at a compound annual growth rate (CAGR) of 14.1%. The growth in the historic period can be attributed to clinical research and trials, increasing incidence of cancer, patient awareness and education, globalization of pharmaceutical industry.

The paclitaxel injection market size is expected to see rapid growth in the next few years. It will grow to $11.17 billion in 2029 at a compound annual growth rate (CAGR) of 12.9%. The growth in the forecast period can be attributed to personalized medicine approaches, biosimilar development, rising cancer burden in aging population, advancements in drug delivery systems, healthcare policy changes. Major trends in the forecast period include integration of ai in oncology, telemedicine and remote healthcare services, technological innovations in drug delivery, integration of drug delivery technologies, rise of biosimilars.

The anticipated rise in breast cancer cases is poised to drive the growth of the paclitaxel injection market in the future. Breast cancer, characterized by abnormal cell growth in the breast, often forming tumors, is a prevalent condition. Paclitaxel injection, a chemotherapy drug, is instrumental in treating breast cancer by binding to microtubules, disrupting the growth of cancer cells. According to the American Cancer Society's January 2023 estimate, approximately 297,790 new cases of invasive breast cancer are expected in the US, leading to an estimated 43,700 deaths in 2023. Thus, the increasing incidence of breast cancer is a significant factor propelling the growth of the paclitaxel injection market.

The increasing incidence of cancer is anticipated to drive the growth of the paclitaxel injection market in the future. Factors such as the rising consumption of tobacco and alcohol, along with the prevalence of smoking, are contributing to the growing number of cancer cases worldwide. Paclitaxel is a chemotherapy drug widely used to treat various cancers, including breast, lung, and ovarian cancer. As the number of cancer cases rises, there will be a higher demand for chemotherapy, with paclitaxel being an essential part of many treatment regimens. For example, in May 2024, the National Cancer Institute, a US-based government agency focused on cancer research and training, projected that the global number of new cancer cases per year is expected to reach 29.9 million, along with 15.3 million cancer-related deaths by 2040. Therefore, the increasing incidence of cancer is propelling the growth of the paclitaxel injection market.

Leading companies in the paclitaxel injection market are focusing on developing innovative products using advanced materials, such as protein-bound particles, to deliver reliable services to consumers. Protein-bound particles (PBPs) represent a drug delivery system that employs albumin, a naturally occurring blood protein, to bind with a drug. For example, in April 2022, Apotex Corp, a US-based pharmaceutical firm, introduced Paclitaxel protein-bound particles for injection (albumin-bound), a generic alternative to Abraxane for the first-line treatment of locally advanced or metastatic non-small cell lung cancer and for metastatic breast cancer. This formulation is administered through intravenous infusion and was launched by American Regent, Inc. as an alternative to Abraxane.

Key players in the paclitaxel injection market are also concentrating on developing innovative products, such as albumin-bound paclitaxel solutions, to broaden treatment options for patients with specific cancer types, offering potentially life-extending therapies. The albumin-bound paclitaxel solution is a solvent-free formulation of the chemotherapy drug paclitaxel, designed to improve drug delivery and minimize toxicity by using albumin nanoparticles to target tumor sites directly. For instance, in May 2023, American Regent, Inc., a US-based injectable manufacturer, launched Paclitaxel Protein-Bound Particles for Injectable Suspension (Albumin-Bound), providing an alternative to Abraxane. This groundbreaking product functions as a microtubule inhibitor for the treatment of metastatic breast cancer, non-small cell lung cancer, and metastatic adenocarcinoma of the pancreas. Its significance lies in the potential to offer a life-extending treatment option for patients while aiding the company's expansion into the oncology market, further underscoring the importance of domestically manufactured medications.

Major companies operating in the paclitaxel injection market report are Pfizer Inc., Bristol-Myers Squibb Company, Fresenius Kabi Oncology Ltd., Abbott Laboratories, Viatris Inc., Teva Pharmaceutical Industries Limited, Sandoz International GmbH, Hospira Inc., Dr. Reddy's Laboratories Ltd., Apotex Inc., Intas Pharmaceuticals Ltd., Zydus Lifesciences Limited, Torrent Pharmaceuticals Ltd., Luye Pharma Group, Biological E Limited, Alembic Pharmaceuticals Limited, Khandelwal Laboratories Pvt. Ltd., Gland Pharma Limited, Abraxis Bio Science Inc., Novasep Holding SAS, Sagent Pharmaceuticals Inc., Hainan Haiyao Co Ltd., Accord Healthcare Ltd., Natco Pharma Limited, Strides Pharma Science Limited, Panacea Biotec Ltd., American Regent Inc., MSN Laboratories Pvt Ltd., Hetero Drugs Ltd.

North America was the largest region in the paclitaxel injection market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the paclitaxel injection market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the paclitaxel injection market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The paclitaxel injection market consists of sales of conventional paclitaxel injection, albumin-bound paclitaxel injection, nanoparticle albumin-bound paclitaxel, and liposomal paclitaxel. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Paclitaxel Injection Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on paclitaxel injection market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for paclitaxel injection ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The paclitaxel injection market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Natural Paclitaxel; Semi-Synthetic Paclitaxel
• 2) By Drug Strength: 10mg Or mL; 20mg Or mL; 30mg Or mL
• 3) By Indication: Breast Cancer; Prostate Cancer; Testicular Cancer; Non-Small Cell Lung Cancer; Lung Cancer; Other Indications
• 4) By Distribution Channel: Hospital Pharmacies; Online Pharmacies; Retail Pharmacies
• 5) By End User: Hospitals; Clinics; Cancer Research Institute
• Subsegments:
• 1) By Natural Paclitaxel: Paclitaxel From Pacific Yew Tree; Paclitaxel From Other Natural Sources
• 2) By Semi-Synthetic Paclitaxel: Docetaxel (Taxotere); Other Semi-Synthetic Variants
• Companies Mentioned: Pfizer Inc.; Bristol-Myers Squibb Company; Fresenius Kabi Oncology Ltd.; Abbott Laboratories; Viatris Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Paclitaxel Injection Market Characteristics

3. Paclitaxel Injection Market Trends And Strategies

4. Paclitaxel Injection Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Paclitaxel Injection Growth Analysis And Strategic Analysis Framework

• 5.1. Global Paclitaxel Injection PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Paclitaxel Injection Market Growth Rate Analysis
• 5.4. Global Paclitaxel Injection Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Paclitaxel Injection Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Paclitaxel Injection Total Addressable Market (TAM)

6. Paclitaxel Injection Market Segmentation

• 6.1. Global Paclitaxel Injection Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Natural Paclitaxel
• Semi-Synthetic Paclitaxel
• 6.2. Global Paclitaxel Injection Market, Segmentation By Drug Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10mg Or mL
• 20mg Or mL
• 30mg Or mL
• 6.3. Global Paclitaxel Injection Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Breast Cancer
• Prostate Cancer
• Testicular Cancer
• Non-Small Cell Lung Cancer
• Lung Cancer
• Other Indications
• 6.4. Global Paclitaxel Injection Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Online Pharmacies
• Retail Pharmacies
• 6.5. Global Paclitaxel Injection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Cancer Research Institute
• 6.6. Global Paclitaxel Injection Market, Sub-Segmentation Of Natural Paclitaxel, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Paclitaxel From Pacific Yew Tree
• Paclitaxel From Other Natural Sources
• 6.7. Global Paclitaxel Injection Market, Sub-Segmentation Of Semi-Synthetic Paclitaxel, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Docetaxel (Taxotere)
• Other Semi-Synthetic Variants

7. Paclitaxel Injection Market Regional And Country Analysis

• 7.1. Global Paclitaxel Injection Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Paclitaxel Injection Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Paclitaxel Injection Market

• 8.1. Asia-Pacific Paclitaxel Injection Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Paclitaxel Injection Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Paclitaxel Injection Market, Segmentation By Drug Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Paclitaxel Injection Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Paclitaxel Injection Market

• 9.1. China Paclitaxel Injection Market Overview
• 9.2. China Paclitaxel Injection Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Paclitaxel Injection Market, Segmentation By Drug Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Paclitaxel Injection Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Paclitaxel Injection Market

• 10.1. India Paclitaxel Injection Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Paclitaxel Injection Market, Segmentation By Drug Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Paclitaxel Injection Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Paclitaxel Injection Market

• 11.1. Japan Paclitaxel Injection Market Overview
• 11.2. Japan Paclitaxel Injection Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Paclitaxel Injection Market, Segmentation By Drug Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Paclitaxel Injection Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Paclitaxel Injection Market

• 12.1. Australia Paclitaxel Injection Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Paclitaxel Injection Market, Segmentation By Drug Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Paclitaxel Injection Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Paclitaxel Injection Market

• 13.1. Indonesia Paclitaxel Injection Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Paclitaxel Injection Market, Segmentation By Drug Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Paclitaxel Injection Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Paclitaxel Injection Market

• 14.1. South Korea Paclitaxel Injection Market Overview
• 14.2. South Korea Paclitaxel Injection Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Paclitaxel Injection Market, Segmentation By Drug Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Paclitaxel Injection Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Paclitaxel Injection Market

• 15.1. Western Europe Paclitaxel Injection Market Overview
• 15.2. Western Europe Paclitaxel Injection Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Paclitaxel Injection Market, Segmentation By Drug Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Paclitaxel Injection Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Paclitaxel Injection Market

• 16.1. UK Paclitaxel Injection Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Paclitaxel Injection Market, Segmentation By Drug Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Paclitaxel Injection Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Paclitaxel Injection Market

• 17.1. Germany Paclitaxel Injection Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Paclitaxel Injection Market, Segmentation By Drug Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Paclitaxel Injection Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Paclitaxel Injection Market

• 18.1. France Paclitaxel Injection Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Paclitaxel Injection Market, Segmentation By Drug Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Paclitaxel Injection Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Paclitaxel Injection Market

• 19.1. Italy Paclitaxel Injection Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Paclitaxel Injection Market, Segmentation By Drug Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Paclitaxel Injection Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Paclitaxel Injection Market

• 20.1. Spain Paclitaxel Injection Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Paclitaxel Injection Market, Segmentation By Drug Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Paclitaxel Injection Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Paclitaxel Injection Market

• 21.1. Eastern Europe Paclitaxel Injection Market Overview
• 21.2. Eastern Europe Paclitaxel Injection Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Paclitaxel Injection Market, Segmentation By Drug Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Paclitaxel Injection Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Paclitaxel Injection Market

• 22.1. Russia Paclitaxel Injection Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Paclitaxel Injection Market, Segmentation By Drug Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Paclitaxel Injection Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Paclitaxel Injection Market

• 23.1. North America Paclitaxel Injection Market Overview
• 23.2. North America Paclitaxel Injection Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Paclitaxel Injection Market, Segmentation By Drug Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Paclitaxel Injection Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Paclitaxel Injection Market

• 24.1. USA Paclitaxel Injection Market Overview
• 24.2. USA Paclitaxel Injection Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Paclitaxel Injection Market, Segmentation By Drug Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Paclitaxel Injection Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Paclitaxel Injection Market

• 25.1. Canada Paclitaxel Injection Market Overview
• 25.2. Canada Paclitaxel Injection Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Paclitaxel Injection Market, Segmentation By Drug Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Paclitaxel Injection Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Paclitaxel Injection Market

• 26.1. South America Paclitaxel Injection Market Overview
• 26.2. South America Paclitaxel Injection Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Paclitaxel Injection Market, Segmentation By Drug Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Paclitaxel Injection Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Paclitaxel Injection Market

• 27.1. Brazil Paclitaxel Injection Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Paclitaxel Injection Market, Segmentation By Drug Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Paclitaxel Injection Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Paclitaxel Injection Market

• 28.1. Middle East Paclitaxel Injection Market Overview
• 28.2. Middle East Paclitaxel Injection Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Paclitaxel Injection Market, Segmentation By Drug Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Paclitaxel Injection Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Paclitaxel Injection Market

• 29.1. Africa Paclitaxel Injection Market Overview
• 29.2. Africa Paclitaxel Injection Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Paclitaxel Injection Market, Segmentation By Drug Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Paclitaxel Injection Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Paclitaxel Injection Market Competitive Landscape And Company Profiles

• 30.1. Paclitaxel Injection Market Competitive Landscape
• 30.2. Paclitaxel Injection Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Fresenius Kabi Oncology Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Viatris Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Paclitaxel Injection Market Other Major And Innovative Companies

• 31.1. Teva Pharmaceutical Industries Limited
• 31.2. Sandoz International GmbH
• 31.3. Hospira Inc.
• 31.4. Dr. Reddy's Laboratories Ltd.
• 31.5. Apotex Inc.
• 31.6. Intas Pharmaceuticals Ltd.
• 31.7. Zydus Lifesciences Limited
• 31.8. Torrent Pharmaceuticals Ltd.
• 31.9. Luye Pharma Group
• 31.10. Biological E Limited
• 31.11. Alembic Pharmaceuticals Limited
• 31.12. Khandelwal Laboratories Pvt. Ltd.
• 31.13. Gland Pharma Limited
• 31.14. Abraxis Bio Science Inc.
• 31.15. Novasep Holding SAS

32. Global Paclitaxel Injection Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Paclitaxel Injection Market

34. Recent Developments In The Paclitaxel Injection Market

35. Paclitaxel Injection Market High Potential Countries, Segments and Strategies

• 35.1 Paclitaxel Injection Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Paclitaxel Injection Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Paclitaxel Injection Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료